(Q77118243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

L W Moreland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

Rheumatic Diseases Clinics of North America

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

579-591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

High concentrations of soluble tumor necrosis factor receptors in ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Increased levels of soluble tumor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Evidence of Participation of the Soluble Tumor Necrosis Factor Receptor I in the Host Response to Intrauterine Infection in Preterm Labor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Unraveling function in the TNF ligand and receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Cytokines in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Plasma tumor necrosis factor soluble receptors in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Increased plasma concentrations for type I and II tumor necrosis factor receptors and IL-2 receptors in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Levels of cytokines and cytokine inhibitors in the neutropenic patient with alpha-hemolytic streptococcus shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Elevated levels of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluids of patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Cerebrospinal fluid levels of soluble tumour necrosis factor receptor in acute encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Tumor necrosis factor receptors in the pituitary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Soluble tumor necrosis factor receptors in human inflammatory synovial fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Cytokines and immunoregulatory molecules in malignant glial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

The two different receptors for tumor necrosis factor mediate distinct cellular responses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Cytokine combinations increase p75 tumor necrosis factor receptor binding and stimulate receptor shedding in rheumatoid synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

Elevation of serum soluble tumour necrosis factor (TNF) receptor and IL-1 receptor antagonist levels in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970027-2

7 January 2021

10.1016/S0889-857X(05)70027-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710888%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference